The Viral protein Corona Directs Viral Pathogenesis and Amyloid Aggregation
Kariem Ezzat, Maria Pernemalm, Sandra Pålsson, Thomas C. Roberts, Peter Järver, Aleksandra Dondalska, Burcu Bestas, Michal J. Sobkowiak, Bettina Levänen, Magnus Sköld, Elizabeth A. Thompson, Otto K. Kari, Tatu Lajunen, Yevheniia Ishchenko, Tarja Malm, Matthew J.A. Wood, Ultan F. Power, Sergej Masich, Anders Lindén,Johan K. Sandberg, Janne Lehtiö, Anna-Lena Spetz, Samir EL Andaloussi
Received Date: 16th January 19
Nanoparticles accumulate a layer of host factors on their surface (a protein corona) in biological fluids, which influences the nanoparticle activity. We hypothesized that viruses also constitute nanoparticles in this respect and here we provide evidence for the existence of viral protein coronae that have implications for viral infectivity, immune cell activation and catalysis of amyloid aggregation. We demonstrate that respiratory syncytial virus (RSV), a major cause of respiratory tract infections, accumulates a rich and distinctive protein corona in different biological fluids including human plasma, human bronchoalveolar lavage fluid, non-human primate plasma and fetal bovine serum. Additionally, corona pre-coating differentially affects viral infectivity and its ability to activate human monocyte-derived dendritic cells (moDCs) depending on the biological fluid. Furthermore, we demonstrate that RSV can bind and catalyze the amyloid aggregation of an amyloidogenic peptide derived from the islet amyloid polypeptide (IAPP) via surface-assisted (heterogeneous) nucleation. Similarly, we show that herpes simplex virus type 1 (HSV-1) possesses a protein corona and catalyzes the amyloid aggregation of the amyloid-beta (Aβ42) peptide which is the major constituent of amyloid plaques in Alzheimer's disease (AD). We also show that HSV-1 infection increases Aβ42 aggregation in the hippocampi and cortices of model AD animals. Our results provide a proof-of-concept for the presence of a viral protein corona layer that is dependent on the microenvironment and influences viral-host interactions. Additionally, the demonstration of corona-driven amyloid catalysis illustrates convergence between viral and amyloid pathologies in the extracellular environment suggesting a novel mechanistic link that warrants further investigation.
Read in full at bioRxiv.
This is an abstract of a preprint hosted on an independent third party site. It has not been peer reviewed but is currently under consideration at Nature Communications.